These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 13510144)

  • 1. The effect of topical nitrogen mustard on wound healing.
    HARRIS FL; THOMAS CG
    Surg Gynecol Obstet; 1961 Jun; 112():684-8. PubMed ID: 13711724
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of nitrogen mustard in relation to operations.
    MORALES F; McDONALD GO
    Surg Forum; 1957; 8():173-7. PubMed ID: 13529577
    [No Abstract]   [Full Text] [Related]  

  • 3. REPORT from the Austin Hospital on the use of nitrogen mustard.
    Med J Aust; 1951 Dec; 2(26):888-90. PubMed ID: 14909876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological characterization of cyclic nitrogen mustard phosphamide esters as cancer therapeutic agents].
    BROCK N
    Arzneimittelforschung; 1958 Jan; 8(1):1-9. PubMed ID: 13510143
    [No Abstract]   [Full Text] [Related]  

  • 5. Optical isomers of cysteine in the prevention of leukopenia induced by nitrogen mustard.
    WEISBERGER AS; STORAASLI JP
    J Lab Clin Med; 1954 Feb; 43(2):246-52. PubMed ID: 13130941
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythritol mustard.
    WHITE FR
    Cancer Chemother Rep; 1962 Nov; 24():57-60. PubMed ID: 14000305
    [No Abstract]   [Full Text] [Related]  

  • 7. CHLORAMBUCIL.
    J Am Med Assoc; 1958 Jan; 166(1):50-1. PubMed ID: 13491311
    [No Abstract]   [Full Text] [Related]  

  • 8. Reactions of dibenamine and some congeners with substances of biological interest in relation to the mechanism of adrenergic blockade.
    HARVEY SC; NICKERSON M
    J Pharmacol Exp Ther; 1954 Nov; 112(3):274-90. PubMed ID: 13212639
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic properties, mechanism of action, and application of alkylarylamine; bibliographic review].
    GAERTNER H
    Postepy Hig Med Dosw; 1954; 8(3):411-42. PubMed ID: 13215177
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the dosage range and scattering of effective dosage in the human body in cancer chemotherapy with N-oxide-mustard].
    von Ardenne M; Reitnauer PG
    Z Krebsforsch; 1966; 68(1):54-67. PubMed ID: 4228635
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chlorine cleavage and efficacy of nitrogen mustard compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1958 Jan; 8(1):9-10. PubMed ID: 13510144
    [No Abstract]   [Full Text] [Related]  

  • 12. [Splitting off of chlorine and activity of nitrogen mustards. II. A new mustard group, 2-amino-1, 3-dichloropropane and structurally related compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1958 Oct; 8(10):638-43. PubMed ID: 13607287
    [No Abstract]   [Full Text] [Related]  

  • 13. [N,N-Bis-(2-chlorethyl)-sulfamic acid derivatives. 4. Chlorine cleavability and biological activity in N-lost compounds].
    PREUSSMANN R
    Arzneimittelforschung; 1962 Nov; 12():1119-23. PubMed ID: 13986088
    [No Abstract]   [Full Text] [Related]  

  • 14. Necrotizing uveitis incident to perfusion of intractraial malignancies with nitrogen mustard or related compounds.
    ANDERSON B; ANDERSON B
    Trans Am Ophthalmol Soc; 1960; 58():95-104. PubMed ID: 13683174
    [No Abstract]   [Full Text] [Related]  

  • 15. [Degradation of nitrogen mustard N-oxide in aqueous solutions].
    ARNOLD H; BROCK N; HOHORST HJ
    Arzneimittelforschung; 1957 Dec; 7(12):735-9. PubMed ID: 13499148
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.